🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 19 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 06/11/2023 | 224,31 | 231,79 | 223,04 | 228,18 | +1,67% | 3,90% | 393.900 |
| 03/11/2023 | 229,84 | 231,29 | 224,10 | 224,43 | -1,64% | 3,13% | 352.200 |
| 02/11/2023 | 225,37 | 228,95 | 222,45 | 228,18 | +1,83% | 2,88% | 341.000 |
| 01/11/2023 | 211,70 | 227,23 | 210,00 | 224,08 | +0,55% | 8,14% | 1.087.400 |
| 31/10/2023 | 221,32 | 222,93 | 217,99 | 222,86 | +1,01% | 2,23% | 424.600 |
| 30/10/2023 | 221,97 | 222,72 | 219,07 | 220,63 | +0,64% | 1,64% | 241.500 |
| 27/10/2023 | 224,65 | 224,65 | 218,50 | 219,23 | -2,30% | 2,74% | 283.100 |
| 26/10/2023 | 223,64 | 226,02 | 221,89 | 224,40 | -0,04% | 1,85% | 257.900 |
| 25/10/2023 | 226,47 | 229,35 | 222,78 | 224,50 | -1,20% | 2,90% | 196.600 |
| 24/10/2023 | 224,82 | 227,25 | 223,04 | 227,23 | +1,37% | 1,87% | 179.100 |
| 23/10/2023 | 223,94 | 225,82 | 222,32 | 224,15 | -0,57% | 1,56% | 252.900 |
| 20/10/2023 | 226,72 | 227,53 | 224,89 | 225,43 | -0,17% | 1,16% | 183.700 |
| 19/10/2023 | 230,52 | 230,52 | 223,50 | 225,82 | -1,95% | 3,05% | 374.600 |
| 18/10/2023 | 236,31 | 236,31 | 230,00 | 230,31 | -2,73% | 2,67% | 220.700 |
| 17/10/2023 | 232,67 | 239,24 | 232,52 | 236,77 | +1,66% | 2,89% | 327.200 |
| 16/10/2023 | 233,48 | 234,05 | 231,44 | 232,90 | -0,11% | 1,12% | 135.800 |
| 13/10/2023 | 232,99 | 234,04 | 229,97 | 233,16 | +0,41% | 1,75% | 167.100 |
| 12/10/2023 | 234,63 | 235,23 | 230,00 | 232,20 | -1,01% | 2,23% | 231.700 |
| 11/10/2023 | 230,07 | 235,32 | 230,07 | 234,58 | +1,85% | 2,28% | 318.000 |
| 10/10/2023 | 230,82 | 232,33 | 228,68 | 230,33 | -0,34% | 1,58% | 331.600 |
| 09/10/2023 | 231,81 | 232,61 | 228,79 | 231,11 | -1,38% | 1,65% | 183.000 |
| 06/10/2023 | 228,04 | 235,48 | 227,95 | 234,34 | +2,65% | 3,30% | 374.600 |
| 05/10/2023 | 221,41 | 228,63 | 221,41 | 228,29 | +2,87% | 3,26% | 273.900 |
| 04/10/2023 | 221,54 | 222,54 | 220,11 | 221,93 | +0,20% | 1,10% | 145.200 |
| 03/10/2023 | 220,00 | 221,84 | 217,62 | 221,49 | -0,29% | 1,92% | 211.500 |
| 02/10/2023 | 224,33 | 226,47 | 220,79 | 222,14 | -1,65% | 2,53% | 280.600 |
| 29/09/2023 | 227,13 | 227,76 | 224,78 | 225,87 | -0,07% | 1,31% | 313.100 |
| 28/09/2023 | 232,85 | 234,50 | 224,76 | 226,03 | -2,77% | 4,18% | 379.300 |
| 27/09/2023 | 229,94 | 234,26 | 229,44 | 232,47 | +1,11% | 2,10% | 258.200 |
| 26/09/2023 | 224,86 | 230,02 | 223,68 | 229,91 | +2,61% | 2,82% | 297.700 |